SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-004752
Filing Date
2020-02-25
Accepted
2020-02-26 13:15:35
Documents
1
Period of Report
2020-02-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k021820_lotuspharma.htm 8-K 13423
  Complete submission text file 0001213900-20-004752.txt   14656
Mailing Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071
Business Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071 86-10-63899868
Lotus Pharmaceuticals, Inc. (Filer) CIK: 0001292087 (see all company filings)

IRS No.: 200507918 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32581 | Film No.: 20654600
SIC: 2834 Pharmaceutical Preparations